Back to top

Image: Bigstock

Can Comcast Spoil the Disney-Fox Party?

Read MoreHide Full Article

Tuesday, May 8, 2018

Ahead of the opening bell this Tuesday, we see a surprisingly high number of companies reporting Q1 (calendar) earnings both this morning and after the close this afternoon. True, most of the big names of the quarter have already brought forth their results, but companies like Marriott (MAR - Free Report) , TripAdvisor (TRIP - Free Report) and especially Disney (DIS - Free Report) report after the bell today.

Speaking of Disney, what had looked like a done deal regarding its annexing of 21st Century Fox’s (FOX - Free Report) film, TV and international assets is currently up for debate, as Comcast (CMCSA - Free Report) reportedly gears up to sweeten the pot with its own offer for the creative businesses. The original Disney-Fox deal was for $52 billion; Comcast is looking to secure as much as $60 billion — all cash — to swoop in for those assets itself.

Comcast was already in the mix somewhat, beforehand: it had put in a bid to buy British communications company Sky Broadcasting, or at least the 2/3 of the company Fox doesn’t already currently own. But one important component to all this is whether the proposed AT&T (T - Free Report) -Time Warner merger passes regulatory appeal; while it does not appear to subvert any merger precedents, plenty of resistance for this deal — not least of all from the White House — have clouded this path for months.

Time, as they say, will tell. The morning prior to Disney’s fiscal Q2 earnings report, the Zacks consensus expects $1.68 per share on $14.23 billion for the quarter, representing growth of 12% on the bottom line and 6.7% on the top. Disney has beaten earnings estimates in 3 of the last 4 quarters for a modest trailing 4-quarter average earnings surprise of 4.7%. For more on DIS’s earnings, click here.

Before Tuesday’s open, Dean Foods put up beats on both top and bottom lines for its Q1 earnings report, posting 14 cents per share that beat consensus by 2 cents (a penny higher year over year) on sales of $1.98 billion that outpaced the $1.84 billion analysts were expecting. This is only the second earnings beat for Dean in the past 4 quarters; ahead of its report, the company carried a Zacks Rank #4 (Sell), but had a Zacks Style Score (Value-Growth-Momentum) of A. For more on DF’s earnings, click here.

Mark Vickery
Senior Editor

Questions or comments about this article and/or its author? Click here>>

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>